Sprinklr, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders??? Equity

Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	ESPP	Senior Subordinated Secured Convertible Note	Senior Subordinated Secured Convertible Note ESPP	Common Stock	Common Stock Class A and Class B Common Stock	Common Stock Class A and Class B Common Stock ESPP	Common Stock Class A and Class B Common Stock Senior Subordinated Secured Convertible Note	Additional Paid-in Capital	Additional Paid-in Capital ESPP	Additional Paid-in Capital Senior Subordinated Secured Convertible Note	Additional Paid-in Capital Senior Subordinated Secured Convertible Note ESPP	Treasury Stock	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jan. 31, 2020	102,408,000
Beginning balance at Jan. 31, 2020	$ 245,970
Convertible Preferred Stock
Tender offer repurchases (in shares)	(1,407,000)
Tender offer repurchases	$ (12,730)
Issuance of Series G-1 and Series G-2 convertible preferred stock at $9.25 and $11.00 per share, respectively, net of issuance costs (in shares)	19,902,000
Issuance of Series G-1 and Series G-2 convertible preferred stock at $9.25 and $11.00 per share, respectively, net of issuance costs	$ 191,752
Ending balance (in shares) at Jan. 31, 2021	120,903,000
Ending balance at Jan. 31, 2021	$ 424,992
Beginning balance (in shares) at Jan. 31, 2020						85,626,000	0
Beginning balance at Jan. 31, 2020	(14,445)					$ 3	$ 0			$ 50,117				$ (17,957)	$ (988)	$ (291,590)
Beginning balance (in shares) at Jan. 31, 2020														13,376,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation - equity classified awards	44,159									44,159
Exercise of stock options and vesting of restricted shares (in shares)						9,572,000
Exercise of stock options and vesting of restricted shares	16,333					$ 1				16,332
Tender offer repurchases (in shares)						(755,000)								755,000
Tender offer repurchases	(20,390)									(1,186)				$ (5,874)		(600)
Issuance of common stock to a third party (in shares)						1,013,000
Issuance of common stock to a third party	5,000									5,000
Issuance of common stock warrants	7,639									7,639
Other comprehensive income (loss)	1,775														1,775
Net loss	(37,970)															(37,970)
Ending balance (in shares) at Jan. 31, 2021						95,456,000	0
Ending balance at Jan. 31, 2021	$ 193,853					$ 4	$ 0			122,061				$ (23,831)	787	(330,160)
Ending balance ( in shares) at Jan. 31, 2021														14,131,000
Convertible Preferred Stock
Conversion of convertible preferred stock to common stock upon initial public offering (in shares)	(120,903,000)
Conversion of convertible preferred stock to common stock upon initial public offering	$ (424,992)
Ending balance (in shares) at Jan. 31, 2022	0
Ending balance at Jan. 31, 2022	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common shares (in shares)							18,288,000	552,000
Issuance of common shares	275,973		$ 7,105							275,973	$ 7,105
Conversion of senior subordinated secured convertible notes (in shares)							120,903,000		9,694,000
Conversion of senior subordinated secured convertible notes	0			$ 82,114			$ 4			424,988		$ 82,114
Stock-based compensation - equity classified awards	49,827									49,827
Reclassification of common stock to Class B common stock (in shares)						(103,045,000)	103,045,000
Reclassification of common stock to Class B common stock	0					$ (4)	$ 4
Exercise of stock options and vesting of restricted shares (in shares)						7,589,000	1,999,000
Exercise of stock options and vesting of restricted shares	20,054									20,054
Shares issued upon cashless exercise of common stock warrants (in shares)							230,000
Issuance of common stock under deferred stock compensation plan (in shares)							1,770,000
Other comprehensive income (loss)	(1,607)														(1,607)
Net loss	(111,470)															(111,470)
Ending balance (in shares) at Jan. 31, 2022						0	256,481,000
Ending balance at Jan. 31, 2022	$ 515,849	$ 761				$ 0	$ 8			982,122				$ (23,831)	(820)	(441,630)	$ 761
Ending balance ( in shares) at Jan. 31, 2022	14,130,784													14,131,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update, extensible enumeration	Accounting Standards Update 2016-13 [Member]
Ending balance (in shares) at Jan. 31, 2023	0
Ending balance at Jan. 31, 2023	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common shares (in shares)								1,259,000
Issuance of common shares					$ 10,231			$ 1					$ 10,230
Stock-based compensation - equity classified awards	57,057									57,057
Exercise of stock options and vesting of restricted shares (in shares)							6,014,000
Exercise of stock options and vesting of restricted shares	24,740									24,740
Other comprehensive income (loss)	(3,564)														(3,564)
Other adjustments (in shares)							(13,000)
Net loss	(55,742)															(55,742)
Ending balance (in shares) at Jan. 31, 2023						0	263,741,000
Ending balance at Jan. 31, 2023	$ 549,332					$ 0	$ 9			$ 1,074,149				$ (23,831)	$ (4,384)	$ (496,611)
Ending balance ( in shares) at Jan. 31, 2023	14,130,784													14,131,000